Freespira

Freespira is a digital therapeutics company that offers a non-invasive, drug-free, and FDA-cleared treatment for panic attacks, panic disorder, and post-traumatic stress disorder (PTSD) symptoms. The company primarily serves individuals experiencing these conditions, with a business model centered on providing a four-week at-home treatment program. This program utilizes a proprietary sensor and a connected mobile app to guide users through twice-daily sessions of personalized breathing exercises. The core of Freespira's technology is to normalize the user's breathing patterns by regulating their exhaled carbon dioxide levels and respiratory rate, which are often dysregulated in individuals with panic and PTSD. By training users to stabilize their breathing, the treatment aims to reduce or eliminate panic attacks and other related symptoms within 28 days. The company generates revenue by selling this treatment program, which is authorized and monitored by healthcare professionals. Freespira operates in the mental and behavioral health market, offering a digital alternative to traditional therapies and medications.

Keywords: digital therapeutics, panic attacks, PTSD, behavioral health, medical device, mobile app, at-home treatment, breathing exercises, non-invasive, FDA-cleared